BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+5.38%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$902M
AUM Growth
+$902M
(+4.7%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
1.45%
Top 10 Holdings %
Top 10 Hldgs %
51.32%
Holding
80
New
11
Increased
14
Reduced
16
Closed
11
Top Buys
1 |
ENDP
Endo International plc
ENDP
|
$16M |
2 |
AngioDynamics
ANGO
|
$15.9M |
3 |
XENT
Intersect ENT, Inc
XENT
|
$9.19M |
4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$9.05M |
5 |
Iovance Biotherapeutics
IOVA
|
$8.63M |
Top Sells
1 |
NVRO
NEVRO CORP.
NVRO
|
$20.3M |
2 |
Phio Pharmaceuticals
PHIO
|
$10.9M |
3 |
XNPT
XENOPORT, INC.
XNPT
|
$7.18M |
4 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$6.39M |
5 |
ELOS
Syneron Medical Ltd
ELOS
|
$6.36M |
Sector Composition
1 | Healthcare | 83.75% |